Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target […]